Halozyme Therapeutics

HALO

NASDAQHealth Care

Income Statement

Total Revenue$1.02B

Gross Profit$855.91M

Operating Income$551.48M

EBITDA$656.54M

EBIT$575.23M

Pre-tax Income$503.37M

Net Income$444.09M

Cash Equivalent$155.66M

Total Debt$1.5B

Book Value$320.94M

Book Value Per Share2.53

Return on Equity (ROE)+122.06%

Return on Assets (ROA)+21.52%

Return on Invested Capital (ROI)+23.75%

Net Profit Margin+43.74%

Current Ratio7.80

Quick Ratio6.50

Long-Term Debt / Equity4.14